Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Blood Cancers
FDA Approves Crizotinib for Pediatric/Young Adult ALK+ Anaplastic Large Cell Lymphoma
BY KRISTI ROSA
Cavrotolimod Granted Fast Track Status for Merkel Cell Carcinoma, CSCC
BY KRISTI ROSA
BET Inhibitor Shows Promise in Advanced Solid Tumors, Relapsed/Refractory NHL
BY HAYLEY VIRGIL
Early Study Lays Groundwork for Boosting Immunotherapy Response
BY BRIELLE BENYON
Mental Health Screening Is Needed in Blood Cancer Space
BY RYAN MCDONALD
Ponatinib Approved by FDA for Resistant or Intolerant Chronic-Phase CML
BY KRISTI ROSA
FDA Approves Selinexor Combination for Pretreated Patients with Myeloma
BY BRIELLE BENYON
FDA Approves Rituximab Biosimilar for Treatment of NHL, CLL, GPA, and MPA
BY KRISTI ROSA
Devimistat Granted Fast Track Designation for AML Treatment
BY KRISTI ROSA
Improving Outcomes for Patients Experiencing Financial Toxicity
BY COLLEEN MORETTI
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.